Navigation Links
EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Center's Selection of the OnCore Clinical Research Management System
Date:1/11/2011

MADISON, Wis., Jan. 12, 2011 /PRNewswire/ -- The University of Virginia (UVA) NCI-designated Cancer Center recently made the move from a comparatively sophisticated home-grown clinical trials management system (CTMS) to the OnCore Clinical Research Management System (OnCore-CRM) from Forte Research Systems, Inc.

(Logo:  http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

"We were using a home-grown system that included both Access and Web-based front ends. As a locally-designed system, it fit our workflow well in some ways and offered some modules that were comparable to the best commercial systems," said James H. Harrison, MD, PhD, Director of Biomedical Informatics at the UVA Cancer Center, who helped lead the project to enhance the Cancer Center's informatics infrastructure for clinical research.

While the existing system was good, it had grown incrementally for over 10 years with a number of developers, so aspects of its structure were awkward and difficult to maintain. The system lacked some capabilities of interest to the center such as a standards-based data representation, a unified user interface, and study financials management capabilities.

With the OnCore system, the UVA Cancer Center looks forward to reducing the amount of effort required to maintain their systems and eliminating the need for installed software on users' computers, which had previously caused version management issues. With OnCore, the Cancer Center will now be able to grant access to users via physically remote computers using a standard web browser over the Internet. OnCore also offers more options to be interoperable with other systems throughout the institution as well as with software provided by the NCI's caBIG program.

The choice to upgrade their clinical research informatics was part of a larger objective at the
'/>"/>

SOURCE Forte Research Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Ceregene, Inc. today announced additional ... double-blind, randomized, controlled Phase 2b clinical study of ... designed to deliver the neurotrophic factor neurturin, for ... robust response to CERE-120 in Parkinson,s patients diagnosed ... those diagnosed 10 years or more (p<.005), as ...
(Date:5/20/2013)... , May 21, 2013 ... Assembly, where world,s health ministers gather to address the ... Mental and neurological disorders (MNDs) affect 700 million ... non-communicable disease (NCD) burden ,Do You Mind?, ... the role each can play to collectively address MNDs ...
(Date:5/20/2013)... May 20, 2013 The Board of ... companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, ... Board.  Guy Mayer , an ... of the Board of Directors and David Johnson, an ... director. Before joining OSI as Board ...
Breaking Medicine Technology:Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3
... Medical Receives European CE Mark Approvals for Drug Eluting Balloon... -- HELMOND, The Netherlands, November 16, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... The largest natural allograft available on the market today ... The Musculoskeletal Transplant Foundation (MTF), the nation,s leading provider of ... cm sized grafts of FlexHD®, their hydrated acellular dermal matrix, ...   These two new sizes are the largest ...
Cached Medicine Technology:Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 2Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 3Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 4Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 5Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 6Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 7Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device 8Largest Acellular Dermal Allografts for Abdominal Wall Repair Now Available From MTF 2
(Date:5/21/2013)... Southborough, MA (PRWEB) May 21, 2013 ... a global leader in the development and standardization ... method, jointly developed by Brunswick Laboratories and the ... measuring antioxidants in foods. This decision comes after ... (ERP) chaired by James Harnly of the U.S. ...
(Date:5/21/2013)... Kansas City, MO (PRWEB) May 21, 2013 ... announcing updated news for women who have used the ... patients filing lawsuits alleging blood clot injuries has increased ... those using popular prescription drugs and devices with the ... can find out if others are experiencing similar side ...
(Date:5/21/2013)... Fulton, MD (PRWEB) May 21, 2013 ... don’t often think about. Not only is it more difficult ... down can become tricky. Fortunately, there are a variety of ... extra help. One such product is the raised toilet seat. ... the floor, making it easier to stand back up or ...
(Date:5/20/2013)... CA (PRWEB) May 21, 2013 USA ... A Transcendent Approach to Peak Performance" won the top ... Non-Fiction Category. Chosen over a multitude of international ... global attention and critical acclaim from both mainstream and ... levels - mentally, physically and spiritually. , ...
(Date:5/20/2013)... 2013 Heritage Woods of Gurnee ... County, Illinois, is hosting Breakfast and Bingo at 8:30 ... is located at 3775 Grand Ave. in Gurnee, Illinois, ... Medicaid, who need some help to maintain their independence. ... games of bingo," says Tammy Temaner-Rosas, Director of Marketing ...
Breaking Medicine News(10 mins):Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2
... The US-China Business,Council (USCBC) today encouraged American ... in China in response to the devastating earthquake,that ... member companies have already pledged several million dollars ... to earthquake victims and many,have established matching funds ...
... release earlier this,year, the FDA issued a Public Health ... and cold products should not,be used to treat infants ... and potentially life-threatening side effects can occur from such,use., ... that OTC cough,and cold medicines not be used for ...
... cholesterol-lowering drugs showed some benefits in preliminary trial ... appear to be associated with a lower risk ... fibrillation in postmenopausal women with coronary disease. , ... atrial fibrillation, but it certainly supports the hypothesis ...
... SAN DIEGO, May 15 - RealAge, Inc., ... Life to the Youngest" and,pursue health and wellness ... Award at the 2008 Pharmaceutical Advertising and Marketing,Excellence ... The,RealAge/ARD Marketing Valtrex(R) campaign was honored in the ...
... HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las ... ... May 15 It,s an all-original, all-singing,all-dancing musical journey across America when ... production show. The spectacular is staged June 14 and 15 in Le,Theatre ...
... May 15 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp.,("SXC" or ... leading provider of,pharmacy benefits management services, announces that Mark ... CFO, will present at the,FBR Capital Markets 12th Annual ... SXC,s presentation will take place on Thursday, May 29,2008 ...
Cached Medicine News:Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Saline is Safe Alternative to Harmful Cough and Cold Products 2Health News:Statins May Help Older Women Control Irregular Heartbeat 2Health News:RealAge Wins Silver PhAME Award 2Health News:Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show 2
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Medicine Products: